Capsules seen in a company’s laboratory . (Photographer: Mark Elias/Bloomberg)
Analysts expect drugmakers focusing on Indian markets to outperform in the near to medium term as pricing pressure escalates in the U.S., the biggest contributor to sales for most pharma companies.Sales in the Indian pharmaceutical market jumped 37.2% over the year earlier in the quarter ended June 2021, according to Prabhudas Lilladher. That compares with a 6% year-on-year decline in the April-June 2020 period on account of logistic...